Triumphs And Crises: European Industry Chief Reflects On The Past Ten Years
Medicines For Europe Director General Adrian Van Den Hoven Highlights Achievements
In the second part of a three-part interview with Generics Bulletin, Medicines for Europe director general Adrian van den Hoven discusses the rise in prominence of biosimilars in Europe, reflects on off-patent industry efforts to deal with crises such as the COVID-19 pandemic and the war in Ukraine, and highlights achievements such as the SPC manufacturing waiver.
